Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives

Min Zhou (Shanghai, China), Maxime Patout (Paris, France), Niki Ubags (Lausanne,CH)

Source: ERS webinar 2020: Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives
Number: 0
Disease area: -


Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Min Zhou (Shanghai, China), Maxime Patout (Paris, France), Niki Ubags (Lausanne,CH). Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives. ERS webinar 2020: Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Management of COVID-19: Other drugs and convalescent plasma
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Anti-cancer therapy and monitoring plasma concentration of carboplatin in lung cancer patients receiving hemodialysis
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

The efficacy of convalescent plasma therapy in severe COVID-19 patients: a systematic review
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Year: 2021

CVA: serum ECP in the management of steroid therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Association of serum pneumoproteins with clinical course of COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Assessment of serum leptin level in the Egyptian asthmatic patients
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012

Other drugs and convalescent plasma
Source: Virtual Congress 2020 – Management
Year: 2020

Effective anti-tuberculosis therapy correlates with plasma small RNA
Source: Eur Respir J 2015; 45: 1741-1744
Year: 2015

Principles of optimization of anti-inflammatory therapy in COPD patients (pts) due to C-reactive protein (CRP) level
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy?
Source: Eur Respir J 2001; 18: Suppl. 33, 24s
Year: 2001

Compassionate use of bedaquiline in a cohort of Indian drug resistant tuberculosis(DR-TB) patients
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016

Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 201s
Year: 2007

Efficacy of traditional and combined therapy in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003

Medical treatment and the capacity to deliver multimodality treatment in elderly patients
Source: Annual Congress 2011 - Lung cancer management in the elderly
Year: 2011

Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004

Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010

Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015